本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Adverum Biotechnologies, Inc.

2.21
-0.0600-2.64%
盘后2.210.00000.00%16:04 EDT
成交量:7.42万
成交额:16.68万
市值:4,616.85万
市盈率:-0.31
高:2.32
开:2.25
低:2.21
收:2.27
数据加载中...
2023/03/30

重要事件披露

8-K - Current report
2023/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/13

重要事件披露

8-K - Current report
2022/11/25

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/07/06

重要事件披露

8-K - Current report
2022/06/16

重要事件披露

8-K - Current report
2022/06/06

重要事件披露

8-K - Current report